Cargando…
An interesting case of chronic myeloid leukemia (CML) with T315I mutation raising suspicion of de novo AML, a diagnostic conundrum
Chronic myeloid leukemia (CML) is a myeloproliferative disorder due to translocation between chromosomes (9, 22), known as the “Philadelphia chromosome.” In 2016, the World health organization (WHO) introduced a new clinical entity of de novo acute myeloid leukemia (AML). Both diseases share some co...
Autores principales: | Iqbal, Phool, Shahzad, Aamir, Shahid, Zubair, Ghori, Firdous, Elomri, Halima, Soliman, Dina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206018/ https://www.ncbi.nlm.nih.gov/pubmed/37234472 http://dx.doi.org/10.1002/ccr3.5908 |
Ejemplares similares
-
T315I(+) tyrosine-kinase independent CML cells resistance
por: Nicolini, Franck Emmanuel, et al.
Publicado: (2017) -
COVID-19 suspicion and diagnosis in pregnancy: A big conundrum!
por: Singh, Parul, et al.
Publicado: (2022) -
P673: ASCIMINIB MANAGMENT IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH T315I MUTATION.
por: Kuzmina, Elena, et al.
Publicado: (2023) -
Interstitial lung disease: raising the index of suspicion in primary care
por: D Zibrak, Joseph, et al.
Publicado: (2014) -
Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment
por: Oaxaca, Derrick M., et al.
Publicado: (2016)